Weighted Average Number of Shares Outstanding, Diluted of BIOXYTRAN, INC from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
BIOXYTRAN, INC quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • BIOXYTRAN, INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 88,992,242, a 30% decline year-over-year.
  • BIOXYTRAN, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 138,598,691, a 3.5% increase from 2023.
  • BIOXYTRAN, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 133,973,352, a 19% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

BIOXYTRAN, INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 88,992,242 -37,398,934 -30% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 88,839,723 -87,766,255 -50% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 88,839,723 -74,609,729 -46% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 138,598,691 +4,625,339 +3.5% 01 Oct 2024 31 Dec 2024 10-K 03 Apr 2025 2024 FY
Q3 2024 126,391,176 -10,051,880 -7.4% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 176,605,978 +47,801,189 +37% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 163,449,452 +39,954,161 +32% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 133,973,352 +21,261,047 +19% 01 Oct 2023 31 Dec 2023 10-K 03 Apr 2025 2024 FY
Q3 2023 136,443,056 +20,049,157 +17% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024 2024 Q3
Q2 2023 128,804,789 +17,963,791 +16% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 123,495,291 +12,654,293 +11% 01 Jan 2023 31 Mar 2023 10-Q 19 Apr 2024 2024 Q1
Q4 2022 112,712,305 01 Oct 2022 31 Dec 2022 10-K/A 13 Jan 2025 2023 FY
Q3 2022 116,393,899 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 110,840,998 +7,469,419 +7.2% 01 Apr 2022 30 Jun 2022 10-Q 31 Jul 2023 2023 Q2
Q1 2022 110,840,998 +10,722,769 +11% 01 Jan 2022 31 Mar 2022 10-Q 23 May 2022 2022 Q1
Q2 2021 103,371,579 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 100,118,229 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1

BIOXYTRAN, INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 138,598,691 +4,625,339 +3.5% 01 Jan 2024 31 Dec 2024 10-K 03 Apr 2025 2024 FY
2023 133,973,352 +21,261,047 +19% 01 Jan 2023 31 Dec 2023 10-K 03 Apr 2025 2024 FY
2022 112,712,305 01 Jan 2022 31 Dec 2022 10-K/A 13 Jan 2025 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.